M
Masanari Kodera
Researcher at Kanazawa University
Publications - 45
Citations - 2166
Masanari Kodera is an academic researcher from Kanazawa University. The author has contributed to research in topics: Autoantibody & Dermatomyositis. The author has an hindex of 18, co-authored 41 publications receiving 1773 citations.
Papers
More filters
Journal ArticleDOI
Common and distinct clinical features in adult patients with anti-aminoacyl-tRNA synthetase antibodies: heterogeneity within the syndrome.
Yasuhito Hamaguchi,Manabu Fujimoto,Takashi Matsushita,Kenzo Kaji,Kazuhiro Komura,Minoru Hasegawa,Masanari Kodera,Eiji Muroi,Keita Fujikawa,Mariko Seishima,Hidehiro Yamada,Ryo Yamada,Shinichi Sato,Kazuhiko Takehara,Masataka Kuwana +14 more
TL;DR: Identification of individual anti-ARS Abs is beneficial to define this rather homogeneous subset and to predict clinical outcomes within the “anti-synthetase syndrome.”
Journal ArticleDOI
Clinical correlations with dermatomyositis-specific autoantibodies in adult Japanese patients with dermatomyositis: a multicenter cross-sectional study.
Yasuhito Hamaguchi,Masataka Kuwana,Kana Hoshino,Minoru Hasegawa,Kenzo Kaji,Takashi Matsushita,Kazuhiro Komura,Motonobu Nakamura,Masanari Kodera,Norihiro Suga,Akira Higashi,Koji Ogusu,Kiyohiro Tsutsui,Akira Furusaki,Hiroshi Tanabe,Shunsuke Sasaoka,Yoshinao Muro,Mika Yoshikawa,Naoko Ishiguro,Masahiro Ayano,Eiji Muroi,Keita Fujikawa,Yukihiro Umeda,Masaaki Kawase,Eriko Mabuchi,Yoshihide Asano,Kinuyo Sodemoto,Mariko Seishima,Hidehiro Yamada,Shinichi Sato,Kazuhiko Takehara,Manabu Fujimoto +31 more
TL;DR: Dermatomyositis-specific Abs define clinically distinct subsets and are useful for predicting clinical outcomes in patients with DM.
Journal ArticleDOI
Elevated serum BAFF levels in patients with systemic sclerosis: Enhanced BAFF signaling in systemic sclerosis B lymphocytes
Takashi Matsushita,Minoru Hasegawa,Koichi Yanaba,Masanari Kodera,Kazuhiko Takehara,Shinichi Sato +5 more
TL;DR: Serum BAFF levels were elevated in SSc patients compared with healthy controls and correlated positively with the extent of skin fibrosis, suggesting that BAFF and its signaling in B cells contribute to B cell abnormalities and disease development in patients with SSc.
Journal ArticleDOI
Myositis-specific anti-155/140 autoantibodies target transcription intermediary factor 1 family proteins.
Manabu Fujimoto,Yasuhito Hamaguchi,Kenzo Kaji,Takashi Matsushita,Yuki Ichimura,Masanari Kodera,Naoko Ishiguro,Ikuko Ueda-Hayakawa,Yoshihide Asano,Fumihide Ogawa,Keita Fujikawa,Takuya Miyagi,Eriko Mabuchi,Kenji Hirose,Narihiro Akimoto,Naohito Hatta,Kiyohiro Tsutsui,Akira Higashi,Atsuyuki Igarashi,Mariko Seishima,Minoru Hasegawa,Kazuhiko Takehara +21 more
TL;DR: To identify the 140-kd autoantigen recognized by anti-155/140 autoantibodies that are associated with adult cancer-associated dermatomyositis and juvenile DM and to determine the clinical relevance of anti- 155/140 antibodies in a large cohort is determined.
Journal ArticleDOI
Anti-DFS70 antibodies in 597 healthy hospital workers
Akihiro Watanabe,Masanari Kodera,Kazumitsu Sugiura,Toshikazu Usuda,Eng M. Tan,Yoshinari Takasaki,Yasushi Tomita,Yoshinao Muro +7 more
TL;DR: Considering that anti-DFS70 antibody positivity is rare in patients with systemic autoimmune diseases, introducing the anti-DFS70 antibody examination as a screening test for ANA-positive persons could be used to rule out systemic autoimmune Diseases, resulting in considerable cost-saving potential.